Navigation Links
Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data

ngle therapies could be effectively treated to this goal with Exforge, regardless of previous treatment.
In patients with type 2 diabetes in the same study, Exforge helped an impressive five out of 10 achieve a more aggressive treatment goal of reducing blood pressure to 130/80 mmHg.
"Most patients will require two or more medications to achieve optimal sustained blood pressure control," said Dr. Joseph Izzo, the lead investigator from the Department of Medicine at the State University of New York in Buffalo. "These data show that using Exforge in a real-life setting can get patients who were previously uncontrolled to a healthy blood pressure goal."
Following Swiss and European Union approval in early 2007, Exforge is currently available in Germany, Switzerland and the UK and is planned to be launched in the rest of the EU in 2007/2008. The US Food and Drug Administration (FDA) granted tentative approval for Exforge in December 2006, and this medicine is expected to become available in the US later in 2007 following the expiration of market exclusivity for Norvasc®* (amlodipine).
"Exforge is a very exciting addition to our cardiovascular portfolio," said Dr. James Shannon, Global Head of Development at Novartis Pharma AG. "The fact that nearly 70% of people with high blood pressure still do not have this potentially fatal condition under control demonstrates the need for powerful and more effective therapies."
High blood pressure and its consequences is the world's No. 1 cause of death[5]. This condition, also called hypertension, is when the blood in the body moves through the blood vessels at a higher pressure than normal and causes damage to the arteries, kidneys, brain and ot
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
2. Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
Post Your Comments:
(Date:7/25/2014)... July 25, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... corporate update and report second quarter 2014 financial results ... August 1, 2014. That same day, Arena will host ... Time (5:30 a.m. Pacific Time). The ... domestic callers and 914.495.8552 for international callers. Please specify ...
(Date:7/24/2014)... , July 24, 2014  PTC Therapeutics, Inc. ... Company will host a webcast conference call to report ... update on the company,s business and outlook on Thursday, ... opening of the market. The call ... (973) 935-8152 (international) five minutes prior to the start ...
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11
... Australia, March 12, 2007: Progen Industries Limited,(ASX: PGL; NASDAQ: ... liver cancer data has been accepted for late breaking ... the Liver,(EASL). Progen will also be presenting the results ... Cancer Research (AACR),Annual Meeting 2007. , ,In expectation ...
... - Tyrima Demonstrates Good Safety Profile and Excellent,Pharmacokinetic ... 2007 /PRNewswire/ --,CeNeRx BioPharma, Inc., a clinical stage ... the central,nervous system, today announced top-line results from ... candidate for the treatment,of depression and anxiety. In ...
Cached Medicine Technology:PI-88 Data to be Presented at Key International Conferences 2PI-88 Data to be Presented at Key International Conferences 3CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
(Date:7/25/2014)... As reported by Wood TV 8 in ... Michigan has seen a nearly 500-person increase in heroin related ... was 271 between 1999 and 2002, the toll increased to ... like other states, drug users in Michigan have turned to ... He compared the price of both substances, noting that an ...
(Date:7/25/2014)... human brain can preserve oxygen to protect itself from ... Although dehydration significantly reduces blood flow to the ... compensates by increasing the amount of oxygen it extracts ... understand a lot more about how the human brain ... author Steven Trangmar, a researcher at Brunel University, said ...
(Date:7/25/2014)... Ticket Down is a reliable source for ... at California Memorial Stadium. With the post-World Cup emotions ... organizers of the 2014 Guinness International Champions Cup have brought ... With teams representing La Liga, English Premier League, Serie A, ... best football players from around the world to 12 American ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 This ... current state of the Galactooligosaccharides (GOS) industry ... basic overview of the industry, including definitions, applications ... Chinese domestic market analysis are provided with a ... of the market. A comparison between the international ...
(Date:7/25/2014)... 25, 2014 (HealthDay News) -- Babies seem to learn ... By the time women are 34 weeks pregnant, their ... mother,s voice reciting a familiar nursery rhyme, the researchers ... of sensory stimulation in the developing fetus," Charlene Krueger, ... Florida,s College of Nursing, said in a university news ...
Breaking Medicine News(10 mins):Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Rhymes Reveal Evidence of Learning in the Womb 2
... Texas, May 11 The Texas Cardiac Arrhythmia Institute ... than 2,300 patients with heart rhythm disorders since it ... of them from outside Central Texas."In just one year, ... at St. David,s Medical Center, coupled with our unmatched ...
... to Older Americans, Nursing Home Residents and Stroke ... Jersey,s largest family-owned and operated senior care provider ... use of computer technology account for speedier recovery ... averages.Independent research data demonstrate that 91 percent of ...
... officials say, and most cases remain mild , , MONDAY, May ... spread across the United States -- and most cases continue ... they,re shifting their focus from individual cases of infection to ... virus in the fall. , The U.S. Centers for Disease ...
... (OTC Bulletin Board: GNPH) (the "Company"), a U.S.,pharmaceutical company ... today announced that its stock will start trading on ... symbol "JGBO" as of May 12, 2009.,The Company,s shares ... the,end of May 11, 2009. , ...
... WASHINGTON Children who suffer traumatic brain injuries can ... for careful watching over time, according to two studies ... one study, a team of psychologists used a longitudinal ... expect after traumatic brain injury (TBI). The researchers found ...
... with ALS and the widow of a military veteran who passed away ... of the Unknowns during a ceremony sponsored by The ALS Association. ... ... with ALS and the widow of a military veteran who passed away ...
Cached Medicine News:Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 3Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 4Health News:State-of-the-Art Technology and Hotel-Like Environment Get CareOne's Rehab Patients Home Quicker 2Health News:State-of-the-Art Technology and Hotel-Like Environment Get CareOne's Rehab Patients Home Quicker 3Health News:CDC Shifts Swine Flu Focus to Likely Impact in the Fall 2Health News:CDC Shifts Swine Flu Focus to Likely Impact in the Fall 3Health News:CDC Shifts Swine Flu Focus to Likely Impact in the Fall 4Health News:CDC Shifts Swine Flu Focus to Likely Impact in the Fall 5Health News:CDC Shifts Swine Flu Focus to Likely Impact in the Fall 6Health News:CDC Shifts Swine Flu Focus to Likely Impact in the Fall 7Health News:CDC Shifts Swine Flu Focus to Likely Impact in the Fall 8Health News:Jiangbo Pharmaceuticals Announces New Ticker (JGBO) and CUSIP 2Health News:Traumatic brain injury haunts children for years with variety of functional problems: Two studies 2Health News:Traumatic brain injury haunts children for years with variety of functional problems: Two studies 3Health News:Traumatic brain injury haunts children for years with variety of functional problems: Two studies 4Health News:Military Veterans Struck Down by Lou Gehrig's Disease Honored on Mother's Day by The ALS Association with Wreath Laying Ceremony at Arlington National Cemetery 2
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
Inquire...
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
Medicine Products: